Skip to content

Metal-organic cage-mediated synergistic tumor microenvironment remodeling and self-enhanced photodynamic therapy.

Aug 2026 · Colloids and Surfaces B: Biointerfaces · Vol 268 Pt 2, pp. 116074 · 0 citations
Medicine

TL;DR

In vivo antitumor studies demonstrate that PFD released in situ remodels TME by downregulating hyaluronic acid and type I collagen expression, normalizing tumor vasculature, improving intratumoral oxygen perfusion and contributing to amplified PDT.

View source

Similar papers

Open access Sep 2026

Rational Design of Porphyrin-Based Nano-Prodrug for Overcoming ROS Resistance and Synergistic Photodynamic Cancer Therapy.

Porphyrin-based photosensitizers (PSs) are among the most widely explored agents for photodynamic therapy (PDT), yet their clinical translation is severely limited by poor biocompatibility, aggregation-induced quenching, insufficient tumor selectivity, and the intrinsic reactive oxygen species (ROS) resistance of cance...

Yi-Hui Ai, Chong-Zhi Wu, Zhi-Yao Li et al. · 0 citations
Open access Sep 2026

Self-Enhancing Photodynamic / Immunotherapy via a MOF Nanoplatform for Combined STING Activation and Immune Checkpoint Blockade.

Combinational photodynamic and immune checkpoint blockade (PDT/ICB) therapy is a promising approach for oncotherapy. However, the tumor microenvironment (TME) poses multiple biological barriers that can critically undermine the treatment outcomes of PDT/ICB. To this end, a cascade-amplified photodynamic immunotherapy n...

Bei Liu, Jia-Yi Zhang, Wen-Fei Xu et al. · 0 citations
Sep 2026

Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition

Photothermal therapy (PTT) offers the advantages of noninvasiveness and high selectivity, while chemotherapy shows potent antitumor activity. However, their standalone applications are limited by insufficient photothermal ablation efficacy and chemotherapeutic resistance, respectively. To address these challenges, we...

Yu Jiang, Chen Guo, Zhen-Kun Sun et al. · 0 citations
Open access Sep 2026

Self-Assembled Cationic Phthalocyanine Nanophotosensitizer Drives Hypoxia-Tolerant Photodynamic Immunotherapy for HCC

Background Photodynamic therapy (PDT) eliminates malignancies through spatially controlled reactive oxygen species (ROS) generation and has achieved clinical success in localized tumors. Nevertheless, its therapeutic potential is severely restricted by the poor aqueous solubility, suboptimal ROS generation efficiency,...

Fang-Cheng Jiang, Yue Qin, Li Gao et al. · 0 citations
Aug 2026

A Chloroplast-Inspired Theranostic Nanoplatform for Self-Sustaining Oxygen-Elevating Photodynamic Therapy and Glutathione-Triggered Carbon-Centered Radical Synergistic Therapy.

This work reports a novel strategy for developing a theranostic nanoplatform for long-lasting PDT activated by 1530 nm laser irradiation and glutathione (GSH)-triggered carbon-centered radical synergistic therapy that responds specifically to the TME.

Jitong Gong, Yu Liu, Qing-Kun Yang et al. · 0 citations
Review Open access Aug 2026

Recent advances in photodynamic therapy systems based on pillar[n]arene host–guest chemistry

Photodynamic therapy (PDT) is a minimally invasive and low-toxicity strategy for tumors and bacterial infections. However, conventional small-molecule photosensitizers have poor water solubility, severe aggregation-caused quenching and weak tumor targeting, restricting their clinical translation. Macrocyclic host-guest...

Fuqiang Zhao, Zhi-Hong Zhu, Liang Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.